Upcoming webinar: “The Discovery of Seqitope® and Opti-mAb® Technologies” 

Written By Kaung Naung

Join us for an in-depth seminar with AAX Biotech’s Co-Founders Dr. Daniel X. Johansson, PhD and Dr. Mats AA Persson, MD, PhD, hosted by SciLifeLab Drug Discovery & Development (DDD).  

We will explore the origins and therapeutic impact of our pioneering platforms for the next generation of antibody therapeutics: Seqitope® and Opti-mAb®. Daniel and Mats will discuss how our technologies address fundamental challenges in antibody engineering to create more effective and scalable therapeutics. 

Event Details:  
Date: February 12, 2026  
Time: 15:00–16:00 CET  
Format: Webinar 

👉 Register and read more here: https://www.linkedin.com/events/pulsechallenge-thediscoveryofse7421816046115807233/

Kaung Naung
Next

AAX Biotech Joins NOME